Nitric oxide-independent dilation of conductance coronary arteries to acetylcholine in conscious dogs

Circulation Research

Volumn 81, Issue 6, 1997, Pages 977-987

  Ming, Zhi ^b   Parent, Robert ^b   Lavallée, Michel ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b NONE

Author keywords

Acetylcholine; Coronary artery; Cytochrome P 450; Nitric oxide; Phospholipase A2

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CELL MEMBRANE CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; EPICARDIUM MAPPING; HYPERPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE;

EID: 0030784440     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.6.977     Document Type: Article

References (44)

1. Chu A, Chambers DE, Lin C-C, Kuehl WD, Palmer RMJ, Moncada S, Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J clin Invest. 1991;87:1964-1968.
2. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 1993;73:829-838.
3. Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375-384.
4. Bassenge E. Endothelium-mediated regulation of coronary tone. Basic Res Cardiol. 1991;86(suppl 2):69-76.
5. Woodman OL, Dusting GJ. N-Nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilation in anaesthetized greyhounds. Br J Pharmacol. 1991;103:1407-1410.
6. Zanzinger J, Bassenge E. Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NOsynthesis and captopril. Eur Heart J. 1993;14(suppl I):164-168.
7. Stewart JM, Wang J, Hintze TH. Role of EDRF in the regulation of shear rate in large coronary arteries in conscious dogs. J Mol Cell Cardiol. 1994;26:1625-1633.
8. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988; 93:515-524.
9. Zygmunt PM, Högestätt ED. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol. 1996;117:1600-1606.
10. Nagao T, Illiano S, Vanhoutte PM. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br J Pharmacol. 1992;107:382-386.
11. Mombouli J-V, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol. 1996;117:413-418.
12. Nagao T, Vanhoulte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery J Physiol (Lond). 1992;445:355-367.
13. Cohen RA, Vanhoutte PM. Endothelium-dependent hypetpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
14. G-nitro-L-arginine in rat aorta. Eur J Pharmacol. 1995;274:25-32.
15. Eckman DM, Weinert JS, Buxton ILO, Keef KD. Cyclic GMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery. Br J Pharmacol. 1994;111:1053-1060.
16. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol. 1994;113:1548-1553.
17. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P-450-derived arachidonic acid metabolite in mammals. J Physiol (Lond). 1994;481:407-414.
18. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
19. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res. 1995;32:79-92.
20. 2 in prostaglandin biosynthesis. Biochem Pharmacol. 1976;25:285-291.
21. Capdevila J, Gil L, Orellana M, Marnett JI, Mason JI, Yadagiri P, Falck JR. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 1988;261:257-263.
22. Parent R, Hamdad N, Ming Z, Lavallée M. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res. 1996;31:555-567.
23. Hamdad N, Mine Z, Parent R, Lavallée M. β2-Adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Am J Physiol. 1996;271:H1926-H1937.
24. Hartley CJ, Cole JS. An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol. 1974;37:626-629.
25. Gwirtz PA. Construction and evaluation of a coronary catheter for chronic implantation in dogs. J Appl Physiol. 1986;60:720-726.
26. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw-Hill Book Co; 1971:514-603, 752-812.
27. Glantz SA. Primer of Biostatistics. 2nd ed. New York, NY: McGraw-Hill Book Co; 1987:245-286.
28. Hintze TH, Vatner SF. Reactive dilation of large coronary arteries in conscious dogs. Circ Res. 1984;54:50-57.
29. Huckstorf C, Zanzinger J, Fink B, Bassenge E. Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs. Naunyn Schtmiedebergs Arch Pharmacol. 1994;349:367-373.
30. Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol. 1984;6:1161-1169.
31. Hintze TH, Vatner SF. Purinergic control of large coronary arteries in the conscious dog. Bibl Cardiol. 1984;38:189-199.
32. Mombouli J-V, Bissiriou I, Agboton VD, Vanhoutte PM. Bioassay of endothelium-derived hyperpolarizing factor. Biochem Biophys Res Commun. 1996;221:484-488.
33. Chen G, Chung DW. Modulation of endothelium-dependent hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity. Circ Res. 1996;79:827-833.
34. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol. 1995;114:99-102.
35. Corriu C, Félétou M, Canet M, Vanhoutte PM. Inhibitors of the cytochrome P45U-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br J Pharmacol 1996;117:607-610.
36. Oyekan AO, McGiff JC, Rosencrantz-Weiss P, Quilley J. Relaxant responses of rabbit aorta: influence of cytochrome P450 inhibitors. J Pharmacol Exp Ther. 1994;268:262-269.
37. + channels by cytochrome P-450 inhibitors. J Biol Chem. 1992;267:11789-11793.
38. Best L, Sener A, Mathias PCF, Malaisse WJ. Inhibition by mepacrince and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets. Biochem Pharmacol. 1984;33:2657-2662.
39. Choo LK, Malta E, Mitchelson F. Investigation of the antimuscarinic and other actions of proadifen in-vitro. J Pharm Pharmacol. 1986;38:898-901.
40. 2+ current by quinacrine in smooth muscle cells of the guinea pig. Jpn J Pharmacol. 1996;71:51-60.
41. Smith TP Jr, Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs, Circ Res. 1993;73:232-240.
42. Parent R, Paré R, Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol. 1992;262:H10-H16.
43. Altman JD, Kinn J, Duncker DJ, Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dogs. Cardiovasc Res. 1994;28:119-124.
44. Xu X-P, Tanner MA, Myers PR. Prostaglandin-mediated inhibition of nitric oxide production by bovine aortic endothelium during hypoxia. Cardiovasc Res. 1995;30:345-350.